Podcast 27 Jun 2025
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
This week we spoke to Humacyte founder, Laura Niklason about the real-world applications for lab-grown blood vessels in conflict zones.
- Latest Posts
How can treatment strategies evolve to address the challenges in chronic lymphocytic leukemia?
Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live beyond uncertainty.
In Depth 25 Jun 2025
ALS: how close are we to a cure?
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.
In Depth 24 Jun 2025
Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem
Discover what makes Paris’s biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters in Europe.
News and Trends 23 Jun 2025
Turning plastic into medicine: Closing the loop on pharma production
Find out about the University of Edinburgh’s work to convert our common plastic wast into the wildly used paracetamol.
In Depth 20 Jun 2025
Stem cell therapy: a potential cure for hearing loss?
As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss.
ADVERTISEMENT
ADVERTISEMENT
Podcast 20 Jun 2025
Special Episode: The 2025 BIO International Convention
In this week’s episode we meet three innovators on the floor in Boston and find out what their BIO experience has been like
Best in Biotech 18 Jun 2025
10 cultured meat companies driving sustainable food in 2025
Learn more about 10 of the top cultured meat companies in biotech looking to pave the way for a sustainable future.
In Depth 18 Jun 2025
From undruggable to oral therapy: The rise of STAT6 degraders
Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.
Best in Biotech 17 Jun 2025
Six kidney disease companies you should know about in 2025
Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients’ lives.
In Depth 16 Jun 2025
Did Novo open the Canadian market to GLP-1 generics?
Find out if Novo’s GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee?
In Depth 13 Jun 2025
A new era in migraine treatment: Innovative drugs redefining the field
Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better.
ADVERTISEMENT
